Canada markets open in 7 hours 43 minutes

CytoDyn Inc. (CYDY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1390+0.0034 (+2.51%)
At close: 03:54PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 138.08M
Enterprise Value 167.16M
Trailing P/E N/A
Forward P/E 10.81
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)761.84
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -3.67

Trading Information

Stock Price History

Beta (5Y Monthly) 0.19
52-Week Change 3-48.15%
S&P500 52-Week Change 321.33%
52 Week High 30.4200
52 Week Low 30.1300
50-Day Moving Average 30.1674
200-Day Moving Average 30.1875

Share Statistics

Avg Vol (3 month) 32.23M
Avg Vol (10 day) 3883.03k
Shares Outstanding 5993.37M
Implied Shares Outstanding 6993.37M
Float 8979.97M
% Held by Insiders 10.80%
% Held by Institutions 10.02%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends May 31, 2023
Most Recent Quarter (mrq)Feb 29, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-76.29%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -15.17M
Net Income Avi to Common (ttm)-53.17M
Diluted EPS (ttm)-0.0600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.4M
Total Cash Per Share (mrq)0
Total Debt (mrq)30.49M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.08
Book Value Per Share (mrq)-0.12

Cash Flow Statement

Operating Cash Flow (ttm)-12.74M
Levered Free Cash Flow (ttm)6.84M